All Updates

All Updates

icon
Filter
Funding
Aktiia raises CHF 27 million in funding to advance blood pressure monitoring device; appoints new president
Preventive Healthcare
Feb 27, 2024
This week:
Funding
Immatics raises USD 150 million in public funding
Precision Medicine
Yesterday
Funding
Immatics raises USD 150 million in public funding
Cell & Gene Therapy
Yesterday
Product updates
Asus launches servers with AMD EPYC 9005-series CPUs and MI325X accelerators to enhance product offering
Generative AI Infrastructure
Yesterday
Partnerships
A2Z signs agreement with Trixo for smart cart services in Mexico and Central America
Automated Stores
Yesterday
Product updates
Nikon releases additional powder feeder for metal additive manufacturing
Additive Manufacturing
Oct 10, 2024
Product updates
BigRep launches industrial filament dryer ‘DRYCON'
Additive Manufacturing
Oct 10, 2024
Industry news
Titomic joins DNV's project to standardize additive manufacturing
Additive Manufacturing
Oct 10, 2024
Product updates
Google rolls out ‘Imagen 3’ image-generation model for Gemini users
Foundation Models
Oct 10, 2024
Funding
BaCta raises EUR 3.3 million in pre-seed funding to produce bio-synthetic rubber
Bio-based Materials
Oct 10, 2024
Partnerships
XtalPi's Ailux Biologics licenses AI platform XtalFold to Janssen for biologics discovery and engineering
AI Drug Discovery
Oct 10, 2024
Preventive Healthcare

Preventive Healthcare

Feb 27, 2024

Aktiia raises CHF 27 million in funding to advance blood pressure monitoring device; appoints new president

Funding

  • Aktiia, a blood pressure monitoring wearable developer, has successfully raised CHF 27 million (USD 30 million) in a funding round led by Redalpine, with participation from Khosla Ventures, Molten, Translink Capital, Verve, and 415 Capital. In addition, the company appointed Daniel Graf as its new president and board member.

  • The new funds will be allocated toward advancing the company’s AI-driven blood pressure management technology to address hypertension management. As of February 2024, Aktiia's device has gained over 60,000 customers globally and medical approval in 44 countries.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.